Mom Multi Postnatal Supplementation Trial
The goal of this clinical trial is to learn if a vitamin and mineral supplement designed specifically for women after childbirth can improve their nutrition and health in women who are pregnant or have recently given birth (within 6 weeks). The main question it aims to answer is: Can a postpartum-specific vitamin and m
| Condition(s) | Postnatal Care |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to learn if a vitamin and mineral supplement designed specifically for women after childbirth can improve their nutrition and health in women who are pregnant or have recently given birth (within 6 weeks). The main question it aims to answer is: Can a postpartum-specific vitamin and mineral supplement help improve nutritional status and health outcomes in women after giving birth? Researchers will compare women who take the new postpartum vitamin and mineral supplement to women who take a placebo (fake pills without active ingredients) to see if the supplement improves their nutritional health. Participants will: Attend 2 visits at University of Georgia (1-1.5 hours each) over 12 weeks Participate in 2 phone calls between visits Stop taking other vitamin/ |
| Who can participate | Inclusion criteria: * Healthy, postpartum women (\~4 weeks \[± 2 weeks\]) with infants born term and singleton * Not pregnant during the study period * Able to understand (written and spoken) English or Spanish. Exclusion criteria: * Cardiometabolic disease * Past pregnancy complications (gestational diabetes, hypertension) * malabsorption syndromes (IBS, IBD, Crohn's, Colitis, Celiac) * Caily use of medications which may affect nutrient absorption * chronic alcohol use (\> 4 alcoholic drinks/day) * those prescribed postnatal MVM supplements by their physician * unwilling to discontinue dietary supplementation containing any of the active components in the study product over the study period * Women should not have an allergy or intolerance to active or inactive product ingredients. |
| Ages | 18 Years |
| Sex | Female |
| Lead sponsor | Perelel Inc. |
| Locations | Athens, Georgia, United States |
| Start date | 2025-11-10 |
| NCT ID | NCT07303595 |
| Official listing | https://clinicaltrials.gov/study/NCT07303595 |